TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR)

CUSIP: 87911B209

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM NEW
Total 13F shares
7,473,456
Share change
-634,790
Total reported value
$97,592,000
Put/Call ratio
42%
Price per share
$13.06
Number of holders
38
Value change
-$17,800,070
Number of buys
19
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 87911B209?
CUSIP 87911B209 identifies TKMR - TEKMIRA PHARMACEUTICALS CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) as of Q2 2014

As of 30 Jun 2014, TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,473,456 shares. The largest 10 holders included FRANKLIN RESOURCES INC, BANK OF MONTREAL /CAN/, WELLS FARGO & COMPANY/MN, ALLIANCEBERNSTEIN L.P., BAKER BROS. ADVISORS LP, MARXE AUSTIN W & GREENHOUSE DAVID M, BlackRock Advisors LLC, BOGLE INVESTMENT MANAGEMENT L P /DE/, RENAISSANCE TECHNOLOGIES LLC, and HSBC HOLDINGS PLC. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.